Target Name: KRTAP10-10
NCBI ID: G353333
Review Report on KRTAP10-10 Target / Biomarker Content of Review Report on KRTAP10-10 Target / Biomarker
KRTAP10-10
Other Name(s): High sulfur keratin-associated protein 10.10 | Keratin associated protein 10-10 | keratin associated protein 10-10 | high sulfur keratin-associated protein 10.10 | KAP18.10 | Keratin-associated protein 10.10 | keratin-associated protein 18-10 | Keratin-associated protein 18.10 | Keratin-associated protein 18-10 | KRTAP10.10 | KRTAP18-1 | Keratin-associated protein 10-10 | KRTAP18-10 | KR10A_HUMAN | KAP10.10 | KAP18-10 | KRTAP18.10

KRTAP10-10: A Potential Drug Target and Biomarker

Keratin is a protein that is found in the hair, nails, and skin. It is a complex protein that plays a vital role in the structure and function of these tissues. One of the proteins that is associated with keratin is called KRTAP10-10.

KRTAP10-10 is a protein that is expressed in a variety of tissues, including the skin, hair, nails, and heart. It is highly sulfur-containing, which is why it is often referred to as sulfur-associated protein KRTAP. The sulfur content of KRTAP10-10 makes it a potential drug target and biomarker.

One of the key features of KRTAP10-10 is its sulfur-containing structure. The protein has a total of 106 amino acid residues, and it contains 35 sulfur atoms. The high sulfur content of KRTAP10-10 makes it a potentially interesting drug target.

KRTAP10-10 has been shown to play a role in a variety of physiological processes in the body. For example, it has been shown to be involved in the regulation of cell growth, differentiation, and survival. It has also been shown to be involved in the regulation of inflammation and immune responses.

In addition to its potential role in cellular processes, KRTAP10-10 has also been shown to be involved in the regulation of skin and hair growth. It has been shown to play a role in the development and maintenance of hair and skin, which suggests that it may be a useful biomarker for diseases that affect these tissues.

As a potential drug target, KRTAP10-10 may be used to treat a variety of conditions. For example, it has been shown to be involved in the development of skin cancer, so it may be a useful target for these diseases. It may also be used to treat other conditions that are characterized by the uncontrolled growth of cells, such as cancer, leukemia, and melanoma.

In addition to its potential as a drug target, KRTAP10-10 may also be used as a biomarker for a variety of diseases. For example, it has been shown to be involved in the regulation of cell death, which suggests that it may be a useful biomarker for diseases that affect the body's ability to kill off damaged cells. It may also be used as a biomarker for diseases that affect the skin and hair, such as dandruff, seborrheic dermatitis, and psoriasis.

Overall, KRTAP10-10 is a protein that has the potential to be a drug target and biomarker. Its high sulfur content and its involvement in a variety of physiological processes make it a promising target for researchers to investigate. Further studies are needed to fully understand the role of KRTAP10-10 in the body and its potential as a drug and biomarker.

Protein Name: Keratin Associated Protein 10-10

Functions: In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins

The "KRTAP10-10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRTAP10-10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KRTAP10-11 | KRTAP10-12 | KRTAP10-2 | KRTAP10-3 | KRTAP10-4 | KRTAP10-5 | KRTAP10-6 | KRTAP10-7 | KRTAP10-8 | KRTAP10-9 | KRTAP11-1 | KRTAP12-1 | KRTAP12-2 | KRTAP12-3 | KRTAP12-4 | KRTAP13-1 | KRTAP13-2 | KRTAP13-3 | KRTAP13-4 | KRTAP15-1 | KRTAP16-1 | KRTAP17-1 | KRTAP19-1 | KRTAP19-2 | KRTAP19-3 | KRTAP19-4 | KRTAP19-5 | KRTAP19-6 | KRTAP19-7 | KRTAP19-8 | KRTAP2-1 | KRTAP2-2 | KRTAP2-3 | KRTAP2-4 | KRTAP20-1 | KRTAP20-2 | KRTAP20-3 | KRTAP20-4 | KRTAP21-1 | KRTAP21-2 | KRTAP21-3 | KRTAP22-1 | KRTAP22-2 | KRTAP23-1 | KRTAP25-1 | KRTAP26-1 | KRTAP27-1 | KRTAP29-1 | KRTAP3-1 | KRTAP3-2 | KRTAP3-3 | KRTAP4-1 | KRTAP4-11 | KRTAP4-12 | KRTAP4-2 | KRTAP4-3 | KRTAP4-4 | KRTAP4-5 | KRTAP4-6 | KRTAP4-7 | KRTAP4-8 | KRTAP4-9 | KRTAP5-1 | KRTAP5-10 | KRTAP5-11 | KRTAP5-14P | KRTAP5-2 | KRTAP5-3 | KRTAP5-4 | KRTAP5-5 | KRTAP5-7 | KRTAP5-8 | KRTAP5-9 | KRTAP5-AS1 | KRTAP6-1 | KRTAP6-2 | KRTAP6-3 | KRTAP7-1 | KRTAP8-1 | KRTAP9-1 | KRTAP9-2 | KRTAP9-3 | KRTAP9-4 | KRTAP9-6 | KRTAP9-7 | KRTAP9-8 | KRTAP9-9 | KRTCAP2 | KRTCAP3 | KRTDAP | KSR1 | KSR1P1 | KSR2 | KTI12 | KTN1 | KTN1-AS1 | KXD1 | KY | KYAT1 | KYAT3